Wh. Pearson et Ly. Guo, Synthesis and mannosidase inhibitory activity of 3-benzyloxymethyl analogsof swainsonine, TETRAHEDR L, 42(47), 2001, pp. 8267-8271
Swainsonine (3), an inhibitor of Golgi alpha -mannosidase II, is a clinical
candidate for cancer treatment. In order to avoid potential problems arisi
ng from its co-inhibition of lysosomal mannosidases, we have synthesized 3-
benzyloxymethyl analogs of swainsonine (17 and 18). Initial screening of th
ese new compounds is reported. (C) 2001 Published by Elsevier Science Ltd.